We are live on !
Find out more
Rathbones Group Portfolio holdings
AUM
$27.1B
Turnover
12.71%
1-Year Est. Return
20.2%
This Fund
S&P 500
This Quarter Est. Return
+13.31%
1 Year Est. Return
+20.2%
3 Year Est. Return
+79.31%
5 Year Est. Return
+95.63%
10 Year Est. Return
+508.19%
AUM
$27.1B
AUM Growth
+$2.1B
(+8.4%)
Cap. Flow
+$4.87M
Cap. Flow % of AUM
Cap. Flow %
0.02%
Top 10 Holdings %
Top 10 Hldgs %
39.99%
Holding
700
New
54
Increased
201
Reduced
274
Closed
35
Avg Time Held
4.9
years
Top 10 Avg Time Held
5.7
years
Top 20 Avg Time Held
4.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$132M |
| 2 |
NVIDIA
NVDA
|
+$67.5M |
| 3 |
Marsh
MRSH
|
+$62.9M |
| 4 |
Goldman Sachs
GS
|
+$61.9M |
| 5 |
Monster Beverage
MNST
|
+$60.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuit
INTU
|
+$78.9M |
| 2 |
Accenture
ACN
|
+$78.2M |
| 3 |
O'Reilly Automotive
ORLY
|
+$75.1M |
| 4 |
Brown & Brown
BRO
|
+$69.8M |
| 5 |
Broadridge
BR
|
+$65.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.91% |
| 2 | Financials | 18.06% |
| 3 | Healthcare | 13.92% |
| 4 | Communication Services | 9.24% |
| 5 | Consumer Discretionary | 8.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
651
PepGen
PEPG
$199M
| $57.6K | ﹤0.01% |
32,003
| – | – |
2023 Q3
11 quarters
|
|
652
Vizsla Silver
VZLA
$1.16B
| $56.1K | ﹤0.01% |
17,100
-15,000
| -47% | -$52.1K |
2024 Q3
7 quarters
|
|
653
Biomea Fusion
BMEA
$54.1M
| $54.4K | ﹤0.01% |
37,000
| – | – |
2026 Q1
1 quarter
|
|
654
Iovance Biotherapeutics
IOVA
$6.73B
| $53.5K | ﹤0.01% |
12,854
| – | – |
2023 Q3
11 quarters
|
|
655
Hain Celestial
HAIN
$21.1M
| $49.5K | ﹤0.01% |
88,280
| – | – |
2025 Q2
4 quarters
|
|
656
enCore Energy
EU
$159M
| $45.8K | ﹤0.01% |
35,000
| – | – |
2026 Q1
1 quarter
|
|
657
Lineage Cell Therapeutics
LCTX
$247M
| $45.8K | ﹤0.01% |
35,000
| – | – |
2023 Q3
11 quarters
|
|
658
Autolus Therapeutics
AUTL
$444M
| $44.9K | ﹤0.01% |
28,050
| – | – |
2023 Q3
11 quarters
|
|
659
Sable Offshore Corp
SOC
$604M
| $32.9K | ﹤0.01% |
10,670
| – | – |
2025 Q4
2 quarters
|
|
660
Ur-Energy
URG
$323M
| $17.6K | ﹤0.01% |
13,000
-7,000
| -35% | -$11.4K |
2023 Q1
13 quarters
|
|
661
Blue Gold Ltd
BGL
$6.22M
| $14.3K | ﹤0.01% |
51,246
+30,000
| +141% | +$25K |
2025 Q3
3 quarters
|
|
662
TRX Gold Corp
TRX
$347M
| $11.6K | ﹤0.01% |
14,000
| – | – |
2024 Q2
8 quarters
|
|
663
Orion Digital Corp
ORIO
$21.7M
| $8.99K | ﹤0.01% |
10,333
| – | – |
2025 Q3
3 quarters
|
|
664
Beyond Meat
BYND
$117M
| $8.62K | ﹤0.01% |
383
-5
| -1% | -$117 |
2025 Q4
2 quarters
|
|
|
SRXH
665
SRX Global
SRXH
$23.3M
| $1.81K | ﹤0.01% |
333
| – | – |
2026 Q1
1 quarter
|
|
666
Ares Capital
ARCC
$13.3B
| – | – |
-12,571
| Closed | -$227K | – |
|
667
Avino Silver & Gold Mines
ASM
$885M
| – | – |
-21,100
| Closed | -$134K | – |
|
|
BBU
668
DELISTED
Brookfield Business Partners
BBU
| – | – |
-13,437
| Closed | -$423K | – |
|
669
DELISTED
BioLife Solutions
BLFS
| – | – |
-77,086
| Closed | -$1.47M | – |
|
|
670
Broadridge
BR
$20.3B
| – | – |
-402,622
| Closed | -$65.4M | – |
|
671
Peabody Energy
BTU
$2.76B
| – | – |
-7,295
| Closed | -$240K | – |
|
672
DocuSign
DOCU
$15B
| – | – |
-4,975
| Closed | -$236K | – |
|
673
Dow Inc
DOW
$22.2B
| – | – |
-6,715
| Closed | -$280K | – |
|
674
DRDGold
DRD
$2.21B
| – | – |
-16,575
| Closed | -$487K | – |
|
675
Ecopetrol
EC
$36.2B
| – | – |
-32,650
| Closed | -$489K | – |
|
Similar funds
Rathbones Group's Q2 2026 Portfolio in Review
As of Q2 2026, Rathbones Group held 700 positions worth $27.1B, up 8.4% from $25B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Rathbones Group's Q2 2026 filing shows 54 new, 201 increased, 274 reduced and 35 closed positions. Its largest new stake was Monster Beverage: 1,447,724 shares worth $69.6M. The largest sale was Intuit, an estimated $78.9M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Rathbones Group's largest Q2 2026 buy was Monster Beverage: 1,447,724 shares worth $69.6M.
- Rathbones Group added most to Lam Research in Q2 2026, an estimated $132M increase.
- Rathbones Group's biggest Q2 2026 reduction was Intuit, cutting an estimated $78.9M.
- Rathbones Group fully exited Broadridge in Q2 2026, selling an estimated $65.4M.
- Rathbones Group's ten largest holdings make up 40% of its $27.1B portfolio in Q2 2026.
- Rathbones Group opened 54 new positions and closed 35 in Q2 2026.
- Rathbones Group's portfolio value rose 8.4% quarter-over-quarter to $27.1B.
Based on Rathbones Group's 13F filing for Q2 2026, filed 23 Jul 2026.